GPCR downstream signalling
Maldonado V, Loza-Mejía MA, Chávez-Alderete J. Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19. Medical Hypotheses. 2020 Nov;144():109988. doi: 10.1016/j.mehy.2020.109988.; Ghasemnejad-Berenji M, Pashapour S, Sadeghpour S. Pentoxifylline: A Drug with Antiviral and Anti-Inflammatory Effects to Be Considered in the Treatment of Coronavirus Disease 2019. Med Princ Pract. 2021;30(1):98–100. PMID: 33049737; PMCID: PMC7923888.; Dalamaga M, Karampela I, Mantzoros CS. Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19. Metabolism. 2020 Aug;109():154282. doi: 10.1016/j.metabol.2020.154282.; Armesto S, González Vela C, Sánchez J, Illaro A, Mayorga J, López Sundh AE, Naharro Fernández C, Palmou N, Gómez-Fernández C, González López MA, González-Gay MA. Treating multidrug-resistant psoriasis with brodalumab, apremilast, methotrexate and prednisone combination therapy in the COVID-19 pandemic. Dermatol Ther. 2020 Nov;33(6):e14464. doi: 10.1111/dth.14464. PMID: 33112014.; Giorgi M, Cardarelli S, Ragusa F, Saliola M, Biagioni S, Poiana G, Naro F, Massimi M. Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19? Int J Mol Sci. 2020 Jul 27;21(15). PMID: 32727145; PMCID: PMC7432892.; Hendry BM, Stafford N, Arnold AD, Sangwaiya A, Manglam V, Rosen SD, Arnold J. Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID-19 patients. Pharmacol Res Perspect. 2020 Aug;8(4):e00631. PMID: 32715661; PMCID: PMC7383088.; Farkas K, Kolossváry E, Járai Z. Simple assessment of quality of life and lower limb functional capacity during cilostazol treatment - results of the SHort-tERm cIlostazol eFFicacy and quality of life (SHERIFF) study. Vasa. 2020 Apr;49(3):235–42. doi: 10.1024/0301-1526/a000845. PMID: 31983287.; Phillips JE. Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases. Front. Pharmacol. 2020 Mar 12;11(). doi: 10.3389/fphar.2020.00259.; Hashim PW, Chima M, Kim HJ, Bares J, Yao CJ, Singer G, Chen T, Genece J, Baum D, Kimmel GW, Nia JK, Gagliotti M, Lebwohl MG. Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: A double-blind, randomized, vehicle-controlled trial. Journal of the American Academy of Dermatology. 2020 Feb;82(2):360–5. doi: 10.1016/j.jaad.2019.06.1288.; Singh D, Beeh KM, Colgan B, Kornmann O, Leaker B, Watz H, Lucci G, Geraci S, Emirova A, Govoni M, Nandeuil MA. Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD. Respiratory Research. 2019 Aug 09;20(1):180. doi: 10.1186/s12931-019-1142-7.; Kragstrup TW, Adams M, Lomholt S, Nielsen MA, Heftdal LD, Schafer P, Deleuran B. IL-12/IL-23p40 identified as a downstream target of apremilast in ex vivo models of arthritis. Therapeutic Advances in Musculoskeletal. 2019 Jan;11(). doi: 10.1177/1759720x19828669.; An R, Liu J, He J, Wang F, Zhang Q, Yu Q. PDE3A inhibitor anagrelide activates death signaling pathway genes and synergizes with cell death-inducing cytokines to selectively inhibit cancer cell growth. Am J Cancer Res. 2019;9(9):1905–21. PMID: 31598394; PMCID: PMC6780660.; Liu F, Yu H, Lin C, Elzoghby AO, Hwang T, Fang J. Use of cilomilast-loaded phosphatiosomes to suppress neutrophilic inflammation for attenuating acute lung injury: the effect of nanovesicular surface charge. Journal of Nanobiotechnology. 2018 Mar 30;16(1):35. doi: 10.1186/s12951-018-0364-z.; Filardo EJ. A role for G-protein coupled estrogen receptor (GPER) in estrogen-induced carcinogenesis: Dysregulated glandular homeostasis, survival and metastasis. The Journal of Steroid Biochemistry and Molecular Biology. 2018 Feb;176():38–48. doi: 10.1016/j.jsbmb.2017.05.005.; Liu DY, Wang ZG, Gao Y, Zhang HM, Zhang YX, Wang XJ, Peng D. Effect and safety of roflumilast for chronic obstructive pulmonary disease in Chinese patients. Medicine (Baltimore). 2018 Feb;97(7):e9864. PMID: 29443750; PMCID: PMC5839818.; Nazir M, Senkowski W, Nyberg F, Blom K, Edqvist PH, Jarvius M, Andersson C, Gustafsson MG, Nygren P, Larsson R, Fryknäs M. Targeting tumor cells based on Phosphodiesterase 3A expression. Exp Cell Res. 2017 Dec 15;361(2):308–15. doi: 10.1016/j.yexcr.2017.10.032. PMID: 29107068.; Gonzalez de Valdivia E, Broselid S, Kahn R, Olde B, Leeb-Lundberg LMF. G protein-coupled estrogen receptor 1 (GPER1)/GPR30 increases ERK1/2 activity through PDZ motif-dependent and -independent mechanisms. Journal of Biological Chemistry. 2017 Jun;292(24):9932–43. doi: 10.1074/jbc.m116.765875.; Alexander A, Irving AJ, Harvey J. Emerging roles for the novel estrogen-sensing receptor GPER1 in the CNS. Neuropharmacology. 2017 Feb;113(Pt B):652–60. doi: 10.1016/j.neuropharm.2016.07.003. PMID: 27392633.; Tran Q, Firkins R, Giles J, Francis S, Matnishian V, Tran P, VerMeer M, Jasurda J, Burgard MA, Gebert-Oberle B. Estrogen Enhances Linkage in the Vascular Endothelial Calmodulin Network via a Feedforward Mechanism at the G Protein-coupled Estrogen Receptor 1. Journal of Biological Chemistry. 2016 May;291(20):10805–23. doi: 10.1074/jbc.m115.697334.; Gaudet HM, Cheng SB, Christensen EM, Filardo EJ. The G-protein coupled estrogen receptor, GPER: The inside and inside-out story. Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3():207–19. doi: 10.1016/j.mce.2015.07.016. PMID: 26190834.; Salhiyyah K, Forster R, Senanayake E, Abdel-Hadi M, Booth A, Michaels JA. Pentoxifylline for intermittent claudication. Cochrane Database Syst Rev. 2015 Sep 29;9():CD005262. PMID: 26417854; PMCID: PMC6513423.; Davari AS, Abnous K, Mehri S, Ghandadi M, Hadizadeh F. Synthesis and biological evaluation of novel pyridine derivatives as potential anticancer agents and phosphodiesterase-3 inhibitors. Bioorg Chem. 2014 Dec;57():83–9. doi: 10.1016/j.bioorg.2014.09.003. PMID: 25277835.; Broselid S, Berg KA, Chavera TA, Kahn R, Clarke WP, Olde B, Leeb-Lundberg LMF. G protein-coupled Receptor 30 (GPR30) Forms a Plasma Membrane Complex with Membrane-associated Guanylate Kinases (MAGUKs) and Protein Kinase A-anchoring Protein 5 (AKAP5) That Constitutively Inhibits cAMP Production. Journal of Biological Chemistry. 2014 Aug;289(32):22117–27. doi: 10.1074/jbc.m114.566893.; Prossnitz ER, Barton M: Estrogen biology: new insights into GPER function and clinical opportunities. Mol Cell Endocrinol. 2014 May 25;389(1-2):71-83. doi: 10.1016/j.mce.2014.02.002. Epub 2014 Feb 12.; Maurice DH, Ke H, Ahmad F, Wang Y, Chung J, Manganiello VC. Advances in targeting cyclic nucleotide phosphodiesterases. Nature Reviews Drug Discovery. 2014 Apr 01;13(4):290–314. doi: 10.1038/nrd4228.; Blumer JB, Lanier SM. Activators of G Protein Signaling Exhibit Broad Functionality and Define a Distinct Core Signaling Triad. Molecular Pharmacology. 2014 Mar;85(3):388–96. doi: 10.1124/mol.113.090068.; Filardo EJ, Thomas P. Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology. Endocrinology. 2012 Jul;153(7):2953–62. PMID: 22495674; PMCID: PMC3380306.; Prossnitz ER, Barton M. The G-protein-coupled estrogen receptor GPER in health and disease. Nature Reviews Endocrinology. 2011 Aug 16;7(12):715–26. doi: 10.1038/nrendo.2011.122.; Nobles KN, Xiao K, Ahn S, Shukla AK, Lam CM, Rajagopal S, Strachan RT, Huang T, Bressler EA, Hara MR, Shenoy SK, Gygi SP, Lefkowitz RJ. Distinct Phosphorylation Sites on the ß 2 -Adrenergic Receptor Establish a Barcode That Encodes Differential Functions of ß-Arrestin. Sci. Signal. 2011 Aug 09;4(185). doi: 10.1126/scisignal.2001707.; Yamazaki T, Anraku T, Matsuzawa S: Ibudilast, a mixed PDE3/4 inhibitor, causes a selective and nitric oxide/cGMP-independent relaxation of the intracranial vertebrobasilar artery. Eur J Pharmacol. 2011 Jan 15;650(2-3):605-11. doi: 10.1016/j.ejphar.2010.10.033. Epub 2010 Oct 29.; Thomas P, Alyea R, Pang Y, Peyton C, Dong J, Berg AH. Conserved estrogen binding and signaling functions of the G protein-coupled estrogen receptor 1 (GPER) in mammals and fish. Steroids. 2010 Aug;75(8-9):595–602. doi: 10.1016/j.steroids.2009.11.005.; Hatzelmann A, Morcillo EJ, Lungarella G, Adnot S, Sanjar S, Beume R, Schudt C, Tenor H. The preclinical pharmacology of roflumilast – A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease. Pulmonary Pharmacology & Therapeutics. 2010 Aug;23(4):235–56. doi: 10.1016/j.pupt.2010.03.011.; Ritter SL, Hall RA. Fine-tuning of GPCR activity by receptor-interacting proteins. Nature Reviews Molecular Cell Biology. 2009 Dec;10(12):819–30. doi: 10.1038/nrm2803.; Rolan P, Hutchinson M, Johnson K. Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease. Expert Opin Pharmacother. 2009 Dec;10(17):2897–904. doi: 10.1517/14656560903426189. PMID: 19929708.; Ding Q, Gros R, Limbird LE, Chorazyczewski J, Feldman RD. Estradiol-mediated ERK phosphorylation and apoptosis in vascular smooth muscle cells requires GPR 30. American Journal of Physiology-Cell Physiology. 2009 Nov;297(5):C1178–87. doi: 10.1152/ajpcell.00185.2009.; Nazarian R, Weinberg JM. AN-2728, a PDE4 inhibitor for the potential topical treatment of psoriasis and atopic dermatitis. Curr Opin Investig Drugs. 2009 Nov;10(11):1236–42. PMID: 19876791.; Quinn JA, Graeber CT, Frackelton AR, Kim M, Schwarzbauer JE, Filardo EJ. Coordinate regulation of estrogen-mediated fibronectin matrix assembly and epidermal growth factor receptor transactivation by the G protein-coupled receptor, GPR30. Mol Endocrinol. 2009 Jul;23(7):1052–64. PMID: 19342448; PMCID: PMC2703602.; Rennard S, Knobil K, Rabe KF, Morris A, Schachter N, Locantore N, Canonica WG, Zhu Y, Barnhart F. The efficacy and safety of cilomilast in COPD. Drugs. 2008;68 Suppl 2():3–57. doi: 10.2165/0003495-200868002-00002. PMID: 19105585.; Gurevich VV, Gurevich EV. Rich Tapestry of G Protein-Coupled Receptor Signaling and Regulatory Mechanisms. Molecular Pharmacology. 2008 Aug;74(2):312–6. doi: 10.1124/mol.108.049015.; Lambert NA. Dissociation of heterotrimeric g proteins in cells. Sci Signal. 2008 Jun 24;1(25):re5. doi: 10.1126/scisignal.125re5. PMID: 18577758.; Otto C, Rohde-Schulz B, Schwarz G, Fuchs I, Klewer M, Brittain D, Langer G, Bader B, Prelle K, Nubbemeyer R, Fritzemeier KH. G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol. Endocrinology. 2008 Oct;149(10):4846–56. doi: 10.1210/en.2008-0269. PMID: 18566127.; Smrcka AV. G protein ß? subunits: Central mediators of G protein-coupled receptor signaling. Cellular and Molecular Life Sciences. 2008 May 19;65(14):2191–214. doi: 10.1007/s00018-008-8006-5.; Soundararajan M, Willard FS, Kimple AJ, Turnbull AP, Ball LJ, Schoch GA, Gileadi C, Fedorov OY, Dowler EF, Higman VA, Hutsell SQ, Sundström M, Doyle DA, Siderovski DP. Structural diversity in the RGS domain and its interaction with heterotrimeric G protein alpha-subunits. Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6457–62. PMID: 18434541; PMCID: PMC2359823.; Luttrell LM. Reviews in molecular biology and biotechnology: transmembrane signaling by G protein-coupled receptors. Mol Biotechnol. 2008 Jul;39(3):239–64. doi: 10.1007/s12033-008-9031-1. PMID: 18240029.; Filardo E, Quinn J, Pang Y, Graeber C, Shaw S, Dong J, Thomas P. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology. 2007 Jul;148(7):3236–45. doi: 10.1210/en.2006-1605. PMID: 17379646.; Boswell-Smith V, Spina D. PDE4 inhibitors as potential therapeutic agents in the treatment of COPD-focus on roflumilast. Int J Chron Obstruct Pulmon Dis. 2007;2(2):121–9. PMID: 18044684; PMCID: PMC2695611.; Huang Z, Mancini JA. Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD. Curr Med Chem. 2006;13(27):3253–62. doi: 10.2174/092986706778773040. PMID: 17168849.; Pedram A, Razandi M, Levin ER. Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol. 2006 Sep;20(9):1996–2009. doi: 10.1210/me.2005-0525. PMID: 16645038.; Violin JD, Ren XR, Lefkowitz RJ. G-protein-coupled receptor kinase specificity for beta-arrestin recruitment to the beta2-adrenergic receptor revealed by fluorescence resonance energy transfer. J Biol Chem. 2006 Jul 21;281(29):20577–88. doi: 10.1074/jbc.m513605200. PMID: 16687412.; Gurevich VV, Gurevich EV. The structural basis of arrestin-mediated regulation of G-protein-coupled receptors. Pharmacology & Therapeutics. 2006 Jun;110(3):465–502. doi: 10.1016/j.pharmthera.2005.09.008.; Huang Z, Liu S, Zhang L, Salem M, Greig GM, Chan CC, Natsumeda Y, Noguchi K. Preferential inhibition of human phosphodiesterase 4 by ibudilast. Life Sci. 2006 May 01;78(23):2663–8. doi: 10.1016/j.lfs.2005.10.026. PMID: 16313925.; Oldham WM, Hamm HE. Structural basis of function in heterotrimeric G proteins. Q Rev Biophys. 2006 May;39(2):117–66. doi: 10.1017/s0033583506004306. PMID: 16923326.; Maurice DH. Cyclic nucleotide phosphodiesterase-mediated integration of cGMP and cAMP signaling in cells of the cardiovascular system. Front Biosci. 2005 May 01;10():1221–8. doi: 10.2741/1614. PMID: 15769620.; Jeon YH, Heo Y-, Kim CM, Hyun Y-, Lee TG, Ro S, Cho JM. Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development. Cellular and Molecular Life Sciences. 2005 Mar 29;62(11):1198–220. doi: 10.1007/s00018-005-4533-5.; Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 2005 Mar 11;307(5715):1625–30. doi: 10.1126/science.1106943. PMID: 15705806.; Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology. 2005 Feb;146(2):624–32. doi: 10.1210/en.2004-1064. PMID: 15539556.; Siderovski DP, Willard FS. The GAPs, GEFs, and GDIs of heterotrimeric G-protein alpha subunits. Int J Biol Sci. 2005;1(2):51–66. PMID: 15951850; PMCID: PMC1142213.; Chen CK. The vertebrate phototransduction cascade: amplification and termination mechanisms. Rev Physiol Biochem Pharmacol. 2005;154():101–21. doi: 10.1007/s10254-005-0004-0. PMID: 16634148.; Beeh KM, Beier J, Lerch C, Schulz AK, Buhl R. Effects of piclamilast, a selective phosphodiesterase-4 inhibitor, on oxidative burst of sputum cells from mild asthmatics and stable COPD patients. Lung. 2004;182(6):369–77. doi: 10.1007/s00408-004-2518-z. PMID: 15765929.; Kanda N, Watanabe S. 17ß-Estradiol Stimulates the Growth of Human Keratinocytes by Inducing Cyclin D2 Expression. Journal of Investigative Dermatology. 2004 Aug;123(2):319–28. doi: 10.1111/j.0022-202x.2004.12645.x.; Kristiansen K. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol Ther. 2004 Jul;103(1):21–80. doi: 10.1016/j.pharmthera.2004.05.002. PMID: 15251227.; Cao X, Cismowski MJ, Sato M, Blumer JB, Lanier SM. Identification and characterization of AGS4: a protein containing three G-protein regulatory motifs that regulate the activation state of Gialpha. J Biol Chem. 2004 Jun 25;279(26):27567–74. doi: 10.1074/jbc.m312786200. PMID: 15096500.; Cabrera-Vera TM, Vanhauwe J, Thomas TO, Medkova M, Preininger A, Mazzoni MR, Hamm HE. Insights into G protein structure, function, and regulation. Endocr Rev. 2003 Dec;24(6):765–81. doi: 10.1210/er.2000-0026. PMID: 14671004.; Kanda N, Watanabe S. 17ß-Estradiol Inhibits Oxidative Stress-Induced Apoptosis in Keratinocytes by Promoting Bcl-2 Expression. Journal of Investigative Dermatology. 2003 Dec;121(6):1500–9. doi: 10.1111/j.1523-1747.2003.12617.x.; Wakasugi K, Nakano T, Morishima I. Oxidized human neuroglobin acts as a heterotrimeric Galpha protein guanine nucleotide dissociation inhibitor. J Biol Chem. 2003 Sep 19;278(38):36505–12. doi: 10.1074/jbc.m305519200. PMID: 12860983.; Azzi M, Charest PG, Angers S, Rousseau G, Kohout T, Bouvier M, Piñeyro G. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11406–11. PMID: 13679574; PMCID: PMC208770.; Zhang JY, Nawoschik S, Kowal D, Smith D, Spangler T, Ochalski R, Schechter L, Dunlop J. Characterization of the 5-HT6 receptor coupled to Ca2+ signaling using an enabling chimeric G-protein. Eur J Pharmacol. 2003 Jul 04;472(1-2):33–8. doi: 10.1016/s0014-2999(03)01855-7. PMID: 12860470.; Dessauer CW, Chen-Goodspeed M, Chen J. Mechanism of Galpha i-mediated inhibition of type V adenylyl cyclase. J Biol Chem. 2002 Aug 09;277(32):28823–9. doi: 10.1074/jbc.m203962200. PMID: 12058044.; Feldman DS, Zamah AM, Pierce KL, Miller WE, Kelly F, Rapacciuolo A, Rockman HA, Koch WJ, Luttrell LM. Selective inhibition of heterotrimeric Gs signaling. Targeting the receptor-G protein interface using a peptide minigene encoding the Galpha(s) carboxyl terminus. J Biol Chem. 2002 Aug 09;277(32):28631–40. doi: 10.1074/jbc.m204753200. PMID: 12036966.; Wenzel-Seifert K, Liu HY, Seifert R. Similarities and differences in the coupling of human beta1- and beta2-adrenoceptors to Gs(alpha) splice variants. Biochem Pharmacol. 2002 Jul 01;64(1):9–20. doi: 10.1016/s0006-2952(02)00924-3. PMID: 12106601.; Neves SR, Ram PT, Iyengar R. G protein pathways. Science. 2002 May 31;296(5573):1636–9. doi: 10.1126/science.1071550. PMID: 12040175.; Neubig RR, Siderovski DP. Regulators of G-protein signalling as new central nervous system drug targets. Nat Rev Drug Discov. 2002 Mar;1(3):187–97. doi: 10.1038/nrd747. PMID: 12120503.; Schrör K. The pharmacology of cilostazol. Diabetes Obes Metab. 2002 Mar;4 Suppl 2():S14–9. doi: 10.1046/j.1463-1326.2002.0040s2s14.x. PMID: 12180353.; Filardo EJ, Quinn JA, Frackelton AR, Bland KI. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol. 2002 Jan;16(1):70–84. doi: 10.1210/mend.16.1.0758. PMID: 11773440.; Natochin M, Lester B, Peterson YK, Bernard ML, Lanier SM, Artemyev NO. AGS3 inhibits GDP dissociation from galpha subunits of the Gi family and rhodopsin-dependent activation of transducin. J Biol Chem. 2000 Dec 29;275(52):40981–5. doi: 10.1074/jbc.m006478200. PMID: 11024022.; Peterson YK, Bernard ML, Ma H, Hazard S, Graber SG, Lanier SM. Stabilization of the GDP-bound conformation of Gialpha by a peptide derived from the G-protein regulatory motif of AGS3. J Biol Chem. 2000 Oct 27;275(43):33193–6. doi: 10.1074/jbc.c000509200. PMID: 10969064.; Filardo EJ, Quinn JA, Bland KI, Frackelton AR. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol. 2000 Oct;14(10):1649–60. doi: 10.1210/mend.14.10.0532. PMID: 11043579.; Ma YC, Huang J, Ali S, Lowry W, Huang XY. Src tyrosine kinase is a novel direct effector of G proteins. Cell. 2000 Sep 01;102(5):635–46. doi: 10.1016/s0092-8674(00)00086-6. PMID: 11007482.; Qiao H, Saulnier R, Patryzkat A, Rahimi N, Raptis L, Rossiter J, Tremblay E, Elliott B. Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity. Cell Growth Differ. 2000 Feb;11(2):123–33. PMID: 10714768.; Downes GB, Gautam N. The G protein subunit gene families. Genomics. 1999 Dec 15;62(3):544–52. doi: 10.1006/geno.1999.5992. PMID: 10644457.; Takesono A, Cismowski MJ, Ribas C, Bernard M, Chung P, Hazard S, Duzic E, Lanier SM. Receptor-independent Activators of Heterotrimeric G-protein Signaling Pathways. Journal of Biological Chemistry. 1999 Nov;274(47):33202–5. doi: 10.1074/jbc.274.47.33202.; Cismowski MJ, Takesono A, Ma C, Lizano JS, Xie X, Fuernkranz H, Lanier SM, Duzic E. Genetic screens in yeast to identify mammalian nonreceptor modulators of G-protein signaling. Nat Biotechnol. 1999 Sep;17(9):878–83. doi: 10.1038/12867. PMID: 10471929.; Hamada Y, Kawachi K, Yamamoto T, Nakata T, Kashu Y, Sato M, Watanabe Y. Effects of single administration of a phosphodiesterase III inhibitor during cardiopulmonary bypass: comparison of milrinone and amrinone. Jpn Circ J. 1999 Aug;63(8):605–9. doi: 10.1253/jcj.63.605. PMID: 10478810.; Baker LP, Nielsen MD, Impey S, Metcalf MA, Poser SW, Chan G, Obrietan K, Hamblin MW, Storm DR. Stimulation of Type 1 and Type 8 Ca2+/Calmodulin-sensitive Adenylyl Cyclases by the Gs-coupled 5-Hydroxytryptamine Subtype 5-HT7AReceptor. Journal of Biological Chemistry. 1998 Jul;273(28):17469–76. doi: 10.1074/jbc.273.28.17469.; Tesmer JJ, Sunahara RK, Gilman AG, Sprang SR. Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. Science. 1997 Dec 12;278(5345):1907–16. doi: 10.1126/science.278.5345.1907. PMID: 9417641.; Tefferi A, Silverstein MN, Petitt RM, Mesa RA, Solberg LA. Anagrelide as a new platelet-lowering agent in essential thrombocythemia: mechanism of actin, efficacy, toxicity, current indications. Semin Thromb Hemost. 1997;23(4):379–83. doi: 10.1055/s-2007-996112. PMID: 9263355.; Fields TA, Casey PJ. Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochem J. 1997 Feb 01;321 ( Pt 3)():561–71. PMID: 9032437; PMCID: PMC1218106.; Mochizuki N, Cho G, Wen B, Insel PA. Identification and cDNA cloning of a novel human mosaic protein, LGN, based on interaction with G alpha i2. Gene. 1996 Nov 28;181(1-2):39–43. doi: 10.1016/s0378-1119(96)00456-8. PMID: 8973305.; Luttrell LM, Hawes BE, van Biesen T, Luttrell DK, Lansing TJ, Lefkowitz RJ. Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases. J Biol Chem. 1996 Aug 09;271(32):19443–50. doi: 10.1074/jbc.271.32.19443. PMID: 8702633.; Ono S, Ueda S, Sakuma T, Tanita T, Koika K, Fujimura S. Relaxation of human isolated pulmonary arteries by amrinone. J Cardiovasc Surg (Torino). 1996 Apr;37(2):177–81. PMID: 8675527.; Basi NS, Okuya S, Rebois RV. GTP binding to Gs does not promote subunit dissociation. Cell Signal. 1996 Mar;8(3):209–15. doi: 10.1016/0898-6568(95)02056-x. PMID: 8736705.; Saulnier R, Bhardwaj B, Klassen J, Leopold D, Rahimi N, Tremblay E, Mosher D, Elliott B. Fibronectin fibrils and growth factors stimulate anchorage-independent growth of a murine mammary carcinoma. Exp Cell Res. 1996 Feb 01;222(2):360–9. doi: 10.1006/excr.1996.0045. PMID: 8598224.; Ménard L, Ferguson SS, Barak LS, Bertrand L, Premont RT, Colapietro AM, Lefkowitz RJ, Caron MG. Members of the G protein-coupled receptor kinase family that phosphorylate the beta2-adrenergic receptor facilitate sequestration. Biochemistry. 1996 Apr 02;35(13):4155–60. doi: 10.1021/bi952961+. PMID: 8672451.; Touhara K, Hawes BE, van Biesen T, Lefkowitz RJ. G protein beta gamma subunits stimulate phosphorylation of Shc adapter protein. Proc. Natl. Acad. Sci. U.S.A. 1995 Sep 26;92(20):9284–7. doi: 10.1073/pnas.92.20.9284.; van Biesen T, Hawes BE, Luttrell DK, Krueger KM, Touhara K, Porfiri E, Sakaue M, Luttrell LM, Lefkowitz RJ. Receptor-tyrosine-kinase- and G beta gamma-mediated MAP kinase activation by a common signalling pathway. Nature. 1995 Aug 31;376(6543):781–4. doi: 10.1038/376781a0. PMID: 7651538.; Premont RT, Inglese J, Lefkowitz RJ. Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J. 1995 Feb;9(2):175–82. doi: 10.1096/fasebj.9.2.7781920. PMID: 7781920.; Kleuss C, Raw AS, Lee E, Sprang SR, Gilman AG. Mechanism of GTP hydrolysis by G-protein alpha subunits. Proc. Natl. Acad. Sci. U.S.A. 1994 Oct 11;91(21):9828–31. doi: 10.1073/pnas.91.21.9828.; Premont RT, Koch WJ, Inglese J, Lefkowitz RJ. Identification, purification, and characterization of GRK5, a member of the family of G protein-coupled receptor kinases. Journal of Biological Chemistry. 1994 Mar;269(9):6832–41. doi: 10.1016/s0021-9258(17)37451-3.; Takami S, Getchell TV, McLaughlin SK, Margolskee RF, Getchell ML. Human taste cells express the G protein alpha-gustducin and neuron-specific enolase. Brain Res Mol Brain Res. 1994 Mar;22(1-4):193–203. doi: 10.1016/0169-328x(94)90047-7. PMID: 8015379.; Taussig R, Tang WJ, Hepler JR, Gilman AG. Distinct patterns of bidirectional regulation of mammalian adenylyl cyclases. Journal of Biological Chemistry. 1994 Feb;269(8):6093–100. doi: 10.1016/s0021-9258(17)37574-9.; Morris TA, Fong SL. Characterization of the gene encoding human cone transducin alpha-subunit (GNAT2). Genomics. 1993 Aug;17(2):442–8. doi: 10.1006/geno.1993.1345. PMID: 8406495.; Sterne-Marr R, Gurevich VV, Goldsmith P, Bodine RC, Sanders C, Donoso LA, Benovic JL. Polypeptide variants of beta-arrestin and arrestin3. Journal of Biological Chemistry. 1993 Jul;268(21):15640–8. doi: 10.1016/s0021-9258(18)82304-3.; Taussig R, Iñiguez-Lluhi JA, Gilman AG. Inhibition of adenylyl cyclase by Gi alpha. Science. 1993 Jul 09;261(5118):218–21. doi: 10.1126/science.8327893. PMID: 8327893.; Richardson RM, Kim C, Benovic JL, Hosey MM. Phosphorylation and desensitization of human m2 muscarinic cholinergic receptors by two isoforms of the beta-adrenergic receptor kinase. Journal of Biological Chemistry. 1993 Jun;268(18):13650–6. doi: 10.1016/s0021-9258(19)38697-1.; Attramadal H, Arriza JL, Aoki C, Dawson TM, Codina J, Kwatra MM, Snyder SH, Caron MG, Lefkowitz RJ. Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. Journal of Biological Chemistry. 1992 Sep;267(25):17882–90. doi: 10.1016/s0021-9258(19)37125-x.; Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ. beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science. 1990 Jun 22;248(4962):1547–50. doi: 10.1126/science.2163110. PMID: 2163110.; Mitsuhashi M, Mitsuhashi T, Payan DG. Multiple signaling pathways of histamine H2 receptors. Identification of an H2 receptor-dependent Ca2+ mobilization pathway in human HL-60 promyelocytic leukemia cells. J Biol Chem. 1989 Nov 05;264(31):18356–62. PMID: 2553705.; Lerea CL, Bunt-Milam AH, Hurley JB. Alpha transducin is present in blue-, green-, and red-sensitive cone photoreceptors in the human retina. Neuron. 1989 Sep;3(3):367–76. doi: 10.1016/0896-6273(89)90261-4. PMID: 2534964.; Honerjäger P. Pharmacology of positive inotropic phosphodiesterase III inhibitors. Eur Heart J. 1989 Aug;10 Suppl C():25–31. doi: 10.1093/eurheartj/10.suppl_c.25. PMID: 2553411.; Van Dop C, Medynski DC, Apone LM. Nucleotide sequence for a cDNA encoding the alpha subunit of retinal transducin (GNAT1) isolated from the human eye. Nucleic Acids Res. 1989 Jun 26;17(12):4887. PMID: 2748346; PMCID: PMC318051.; DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant RC, Wright R. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med. 1989 Mar 16;320(11):677–83. doi: 10.1056/nejm198903163201101. PMID: 2646536.; Graziano MP, Freissmuth M, Gilman AG. Expression of Gs alpha in Escherichia coli. Purification and properties of two forms of the protein. J Biol Chem. 1989 Jan 05;264(1):409–18. PMID: 2491850.; Itoh H, Toyama R, Kozasa T, Tsukamoto T, Matsuoka M, Kaziro Y. Presence of three distinct molecular species of Gi protein alpha subunit. Structure of rat cDNAs and human genomic DNAs. Journal of Biological Chemistry. 1988 May;263(14):6656–64. doi: 10.1016/s0021-9258(18)68692-2.; Kozasa T, Itoh H, Tsukamoto T, Kaziro Y. Isolation and characterization of the human Gs alpha gene. Proc. Natl. Acad. Sci. U.S.A. 1988 Apr;85(7):2081–5. doi: 10.1073/pnas.85.7.2081.; Gilman AG. G proteins: transducers of receptor-generated signals. Annu Rev Biochem. 1987;56():615–49. doi: 10.1146/annurev.bi.56.070187.003151. PMID: 3113327.; Ferguson KM, Higashijima T, Smigel MD, Gilman AG. The influence of bound GDP on the kinetics of guanine nucleotide binding to G proteins. Journal of Biological Chemistry. 1986 Jun;261(16):7393–9. doi: 10.1016/s0021-9258(17)38404-1.; Benovic JL, Strasser RH, Caron MG, Lefkowitz RJ. Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. Proc. Natl. Acad. Sci. U.S.A. 1986 May;83(9):2797–801. doi: 10.1073/pnas.83.9.2797.; Weber KT, Janicki JS, Jain MC. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure. J Heart Transplant. 1986 Mar;5(2):105–12. PMID: 2956397.; Alousi AA, Johnson DC. Pharmacology of the bipyridines: amrinone and milrinone. Circulation. 1986 Mar;73(3 Pt 2):III10–24. PMID: 2417744.; Benotti JR, Lesko LJ, McCue JE, Alpert JS. Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart failure. The American Journal of Cardiology. 1985 Oct;56(10):685–9. doi: 10.1016/0002-9149(85)91036-7.; Wilmshurst PT, Walker JM, Fry CH, Mounsey JP, Twort CH, Williams BT, Davies MJ, Webb-Peploe MM. Inotropic and vasodilator effects of amrinone on isolated human tissue. Cardiovasc Res. 1984 May;18(5):302–9. doi: 10.1093/cvr/18.5.302. PMID: 6733734.; Allaf DE, D'orio V, Carlier J. The new inotropic phosphodiesterase inhibitors. Archives Internationales de Physiologie et de Biochimie. 1984 Jan;92(4):S69–79. doi: 10.3109/13813458409071165.; Dage RC, Roebel LE, Hsieh CP, Weiner DL, Woodward JK. Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one). J Cardiovasc Pharmacol. 1982 May;4(3):500–8. PMID: 6177949.